Literature DB >> 1683348

Loss of heterozygosity on chromosome 1p in thyroid adenoma and medullary carcinoma, but not in papillary carcinoma.

K Kubo1, K Yoshimoto, Y Yokogoshi, M Tsuyuguchi, S Saito.   

Abstract

We analyzed 53 loci on 21 chromosomes other than chromosome 4 to detect possible loss of heterozygosity in 31 thyroid tumors using polymorphic DNA markers that detect allelic deletions at specific chromosomal loci. Loss of heterozygosity on chromosomes 1, 7 and 12 was detected in one follicular thyroid adenoma, and on chromosome 1 in two medullary thyroid carcinomas. However, no loss of heterozygosity was detected at any of the loci examined in papillary thyroid carcinomas. These results suggest that chromosomal loss detected in thyroid adenoma is one of the signals for risk of premalignant transformation, and that inactivation of unknown genes on chromosome 1p contributes to tumorigenesis of medullary thyroid carcinoma. Some genetic changes other than chromosomal losses may participate in the tumorigenesis of papillary thyroid carcinoma.

Entities:  

Mesh:

Year:  1991        PMID: 1683348      PMCID: PMC5918246          DOI: 10.1111/j.1349-7006.1991.tb01763.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


multiple endocrine neoplasia restriction fragment length polymorphism thyrotropin medullary thyroid carcinoma
  36 in total

1.  An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor.

Authors:  D A Haber; A J Buckler; T Glaser; K M Call; J Pelletier; R L Sohn; E C Douglass; D E Housman
Journal:  Cell       Date:  1990-06-29       Impact factor: 41.582

Review 2.  Nodular thyroid disease. Evaluation and management.

Authors:  M T Rojeski; H Gharib
Journal:  N Engl J Med       Date:  1985-08-15       Impact factor: 91.245

Review 3.  Human cancer and cellular oncogenes.

Authors:  S Nishimura; T Sekiya
Journal:  Biochem J       Date:  1987-04-15       Impact factor: 3.857

4.  Human p53 gene localized to short arm of chromosome 17.

Authors:  C Miller; T Mohandas; D Wolf; M Prokocimer; V Rotter; H P Koeffler
Journal:  Nature       Date:  1986 Feb 27-Mar 5       Impact factor: 49.962

5.  Cytogenetics of thyroid follicular adenomas.

Authors:  E van den Berg; J W Oosterhuis; B de Jong; J Buist; A Vos; A Dam; B Vermeij
Journal:  Cancer Genet Cytogenet       Date:  1990-02

6.  Identification of a chromosome 18q gene that is altered in colorectal cancers.

Authors:  E R Fearon; K R Cho; J M Nigro; S E Kern; J W Simons; J M Ruppert; S R Hamilton; A C Preisinger; G Thomas; K W Kinzler
Journal:  Science       Date:  1990-01-05       Impact factor: 47.728

7.  Assignment of multiple endocrine neoplasia type 2A to chromosome 10 by linkage.

Authors:  N E Simpson; K K Kidd; P J Goodfellow; H McDermid; S Myers; J R Kidd; C E Jackson; A M Duncan; L A Farrer; K Brasch
Journal:  Nature       Date:  1987 Aug 6-12       Impact factor: 49.962

8.  Struma lymphomatosa (Hashimoto's thyroiditis) and related thyroidal disorders.

Authors:  L B WOOLNER; W M McCONAHEY; O H BEAHRS
Journal:  J Clin Endocrinol Metab       Date:  1959-01       Impact factor: 5.958

9.  Infrequent loss of chromosomal heterozygosity in human stomach cancer.

Authors:  M Wada; J Yokota; H Mizoguchi; T Sugimura; M Terada
Journal:  Cancer Res       Date:  1988-06-01       Impact factor: 12.701

10.  High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis.

Authors:  N R Lemoine; E S Mayall; F S Wyllie; E D Williams; M Goyns; B Stringer; D Wynford-Thomas
Journal:  Oncogene       Date:  1989-02       Impact factor: 9.867

View more
  4 in total

1.  Penetrance and clinical consequences of a gross SDHB deletion in a large family.

Authors:  D C Solis; N Burnichon; H J L M Timmers; M J Raygada; A Kozupa; M J Merino; D Makey; K T Adams; A Venisse; A-P Gimenez-Roqueplo; K Pacak
Journal:  Clin Genet       Date:  2009-04       Impact factor: 4.438

2.  Allelotyping of follicular thyroid tumors.

Authors:  J Zedenius; G Wallin; A Svensson; L Grimelius; A Höög; G Lundell; M Bäckdahl; C Larsson
Journal:  Hum Genet       Date:  1995-07       Impact factor: 4.132

Review 3.  The pituitary tumor transforming gene in thyroid cancer.

Authors:  G D Lewy; N Sharma; R I Seed; V E Smith; K Boelaert; C J McCabe
Journal:  J Endocrinol Invest       Date:  2012-04-05       Impact factor: 4.256

4.  Inactivation of the p53 gene is not required for tumorigenesis of medullary thyroid carcinoma or pheochromocytoma.

Authors:  I Yana; T Nakamura; E Shin; K Karakawa; H Kurahashi; Y Kurita; T Kobayashi; T Mori; I Nishisho; S Takai
Journal:  Jpn J Cancer Res       Date:  1992-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.